There were two main objectives for employing this method: first, to evaluate directly the differentiation and cell proliferation of CD8+ T-cells in older dogs, and second, to contribute to the development of T-cell infusion therapy targeting older cancer-bearing dogs. The gene discussed is CD8A; the disease is cancer.